D Ruggiero-Lopez

Summary

Affiliation: INSA de Lyon
Country: France

Publications

  1. ncbi request reprint Growth modulation of retinal microvascular cells by early and advanced glycation products
    D Ruggiero-Lopez
    Diabetic Microangiopathy Unit, LIPHA INSERM U352, INSA Lyon
    Diabetes Res Clin Pract 34:135-42. 1997
  2. ncbi request reprint Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation
    D Ruggiero-Lopez
    Diabetic Microangiopathy Research Unit, LIPHA INSERM U352, INSA Lyon, Villeurbanne, France
    Biochem Pharmacol 58:1765-73. 1999
  3. ncbi request reprint In vitro and in vivo alterations of enzymatic glycosylation in diabetes
    N Rellier
    Diabetic Microangiopathy Research Unit, LIPHA INSERM U352, INSA Lyon, Villeurbanne, France
    Life Sci 64:1571-83. 1999

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Growth modulation of retinal microvascular cells by early and advanced glycation products
    D Ruggiero-Lopez
    Diabetic Microangiopathy Unit, LIPHA INSERM U352, INSA Lyon
    Diabetes Res Clin Pract 34:135-42. 1997
    ..The inhibitory effect of AGEs observed on pericyte growth, suggests that glycoxidation could be implicated in the pericyte loss observed in diabetic retinopathy...
  2. ncbi request reprint Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation
    D Ruggiero-Lopez
    Diabetic Microangiopathy Research Unit, LIPHA INSERM U352, INSA Lyon, Villeurbanne, France
    Biochem Pharmacol 58:1765-73. 1999
    ..This is relevant to a potential clinical use of metformin in the prevention of diabetic complications by inhibition of carbonyl stress...
  3. ncbi request reprint In vitro and in vivo alterations of enzymatic glycosylation in diabetes
    N Rellier
    Diabetic Microangiopathy Research Unit, LIPHA INSERM U352, INSA Lyon, Villeurbanne, France
    Life Sci 64:1571-83. 1999
    ..The possible consequence of these enzymatic activity changes could be a defect in the carbohydrate content of some glycoproteins that might participate in the endothelial cell dysfunctions in diabetic microangiopathy...